ACA
GBT
Avoro Capital Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,000,000
| Closed | -$48.5M | – | 36 |
|
|
2019
Q3 | $48.5M | Buy |
1,000,000
+50,000
| +5% | +$2.43M | 2.02% | 17 |
|
|
2019
Q2 | $50M | Hold |
950,000
| – | – | 1.73% | 16 |
|
|
2019
Q1 | $50.3M | Buy |
950,000
+600,000
| +171% | +$31.8M | 2.17% | 14 |
|
|
2018
Q4 | $14.4M | Buy |
350,000
+62,500
| +22% | +$2.57M | 0.86% | 22 |
|
|
2018
Q3 | $10.9M | Sell |
287,500
-413,048
| -59% | -$15.7M | 0.5% | 29 |
|
|
2018
Q2 | $31.7M | Sell |
700,548
-1,065,000
| -60% | -$48.1M | 1.22% | 25 |
|
|
2018
Q1 | $85.3M | Sell |
1,765,548
-76,348
| -4% | -$3.69M | 4.07% | 7 |
|
|
2017
Q4 | $72.5M | Buy |
1,841,896
+717,596
| +64% | +$28.2M | 4.7% | 6 |
|
|
2017
Q3 | $34.9M | Buy |
1,124,300
+264,300
| +31% | +$8.21M | 2.71% | 15 |
|
|
2017
Q2 | $23.5M | Buy |
860,000
+45,000
| +6% | +$1.23M | 2.97% | 12 |
|
|
2017
Q1 | $30M | Sell |
815,000
-180,838
| -18% | -$6.66M | 3.84% | 10 |
|
|
2016
Q4 | $14.4M | Buy |
995,838
+126,575
| +15% | +$1.83M | 2.91% | 16 |
|
|
2016
Q3 | $20M | Sell |
869,263
-94,383
| -10% | -$2.18M | 3.52% | 12 |
|
|
2016
Q2 | $16M | Buy |
963,646
+755,560
| +363% | +$12.5M | 3.55% | 12 |
|
|
2016
Q1 | $3.3M | Buy |
+208,086
| New | +$3.3M | 1.15% | 24 |
|